thalidomide has been researched along with 2-(2,6-diisopropylphenyl)-5-amino-1h-isoindole-1,3-dione in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azuma, A; Hashimoto, Y; Kato, F; Kato, M; Kobayashi, Y; Miyachi, H; Ogasawara, A; Uchimura, E; Watanabe, N | 1 |
Hashimoto, Y; Iguchi, T; Inatsuki, S; Kizaki, M; Kobayashi, H; Miyachi, H; Noguchi, T; Oda, S | 1 |
Hashimoto, Y; Katayama, R; Miyachi, H; Naito, M; Noguchi, T | 1 |
Fujimoto, H; Hashimoto, Y; Miyachi, H; Miyajima, A; Noguchi, T; Sano, H | 1 |
de-Blanco, EJ; Hu, Z; Lewis, A; Li, PK; Pandit, B; Shi, J | 1 |
Du, W; Hasegawa, Y; Hattori, Y; Hozumi, M; Ichikawa, D; Matsuo, K; Matsushita, M; Oikawa, T; Ozaki, Y; Shiheido, H; Tabata, N; Terada, F; Yamada, T; Yanagawa, H | 1 |
6 other study(ies) available for thalidomide and 2-(2,6-diisopropylphenyl)-5-amino-1h-isoindole-1,3-dione
Article | Year |
---|---|
Novel biological response modifiers: phthalimides with tumor necrosis factor-alpha production-regulating activity.
Topics: Cell Survival; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Immunologic Factors; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Okadaic Acid; Optical Rotation; Phthalimides; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 1997 |
Tubulin-polymerization inhibitors derived from thalidomide.
Topics: Colchicine; Indoles; Isoindoles; Lactones; Macrolides; Nerve Tissue Proteins; Thalidomide; Time Factors; Tubulin; Tubulin Modulators | 2005 |
Cell differentiation inducers derived from thalidomide.
Topics: Antineoplastic Agents; Cell Differentiation; Drug Screening Assays, Antitumor; Flow Cytometry; HL-60 Cells; Humans; Indoles; Isoindoles; Leukemia; Lipopolysaccharide Receptors; Structure-Activity Relationship; Thalidomide | 2005 |
Angiogenesis inhibitors derived from thalidomide.
Topics: Angiogenesis Inhibitors; Endothelium, Vascular; Humans; Structure-Activity Relationship; Thalidomide; Umbilical Veins | 2005 |
Inhibitors of NF-kappaB derived from thalidomide.
Topics: HeLa Cells; Humans; NF-kappa B; Thalidomide | 2007 |
A novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclasts.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Evaluation, Preclinical; Half-Life; Heterografts; Humans; Lenalidomide; Male; Mice, Inbred ICR; Mice, SCID; Multiple Myeloma; Nuclear Proteins; Nucleophosmin; Osteoclasts; Phthalimides; Thalidomide | 2015 |